{"id":"https://openalex.org/W2000654139","doi":"https://doi.org/10.1158/0008-5472.can-14-1456","title":"IPH4102, a Humanized KIR3DL2 Antibody with Potent Activity against Cutaneous T-cell Lymphoma","display_name":"IPH4102, a Humanized KIR3DL2 Antibody with Potent Activity against Cutaneous T-cell Lymphoma","publication_year":2014,"publication_date":"2014-10-30","ids":{"openalex":"https://openalex.org/W2000654139","doi":"https://doi.org/10.1158/0008-5472.can-14-1456","mag":"2000654139","pmid":"https://pubmed.ncbi.nlm.nih.gov/25361998"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.can-14-1456","doi":"https://doi.org/10.1158/0008-5472.can-14-1456","is_oa":false,"landing_page_url":"https://doi.org/10.1158/0008-5472.can-14-1456","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5061551018","display_name":"Anne Marie\u2010Cardine","orcid":"https://orcid.org/0000-0002-6593-2453","observed_orcids":["https://orcid.org/0000-0002-6593-2453"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210091437","display_name":"Sorbonne Paris Cit\u00e9","ror":"https://ror.org/001z21q04","country_code":"FR","type":"other","lineage":["https://openalex.org/I204730241","https://openalex.org/I4210091437"]},{"id":"https://openalex.org/I4210144610","display_name":"H\u00f4pital Saint-Louis","ror":"https://ror.org/049am9t04","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210144610"]},{"id":"https://openalex.org/I4387154437","display_name":"HIPI -  Immunologie humaine, physiopathologie et immunith\u00e9rapie","ror":"https://ror.org/008e1sp22","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I204730241","https://openalex.org/I4387154437"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Anne Marie-Cardine","raw_affiliation_strings":["1INSERM U976, H\u00f4pital Saint Louis, Paris, France","2University Paris Diderot, Sorbonne Paris Cit\u00e9, UMRS 976, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1INSERM U976, H\u00f4pital Saint Louis, Paris, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210144610","https://openalex.org/I4387154437"]},{"raw_affiliation_string":"2University Paris Diderot, Sorbonne Paris Cit\u00e9, UMRS 976, Paris, France","institution_ids":["https://openalex.org/I4210091437","https://openalex.org/I4387154437"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018349448","display_name":"Nicolas Viaud","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143497","display_name":"Innate Pharma (France)","ror":"https://ror.org/055wa9133","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210143497"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Nicolas Viaud","raw_affiliation_strings":["3INNATE PHARMA, Marseilles, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3INNATE PHARMA, Marseilles, France","institution_ids":["https://openalex.org/I4210143497"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021574889","display_name":"Nicolas Thonnart","orcid":"https://orcid.org/0000-0002-6904-1607","observed_orcids":["https://orcid.org/0000-0002-6904-1607"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210091437","display_name":"Sorbonne Paris Cit\u00e9","ror":"https://ror.org/001z21q04","country_code":"FR","type":"other","lineage":["https://openalex.org/I204730241","https://openalex.org/I4210091437"]},{"id":"https://openalex.org/I4210144610","display_name":"H\u00f4pital Saint-Louis","ror":"https://ror.org/049am9t04","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210144610"]},{"id":"https://openalex.org/I4387154437","display_name":"HIPI -  Immunologie humaine, physiopathologie et immunith\u00e9rapie","ror":"https://ror.org/008e1sp22","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I204730241","https://openalex.org/I4387154437"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Nicolas Thonnart","raw_affiliation_strings":["1INSERM U976, H\u00f4pital Saint Louis, Paris, France","2University Paris Diderot, Sorbonne Paris Cit\u00e9, UMRS 976, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1INSERM U976, H\u00f4pital Saint Louis, Paris, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210144610","https://openalex.org/I4387154437"]},{"raw_affiliation_string":"2University Paris Diderot, Sorbonne Paris Cit\u00e9, UMRS 976, Paris, France","institution_ids":["https://openalex.org/I4210091437","https://openalex.org/I4387154437"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042311326","display_name":"Rachel Joly","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143497","display_name":"Innate Pharma (France)","ror":"https://ror.org/055wa9133","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210143497"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Rachel Joly","raw_affiliation_strings":["3INNATE PHARMA, Marseilles, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3INNATE PHARMA, Marseilles, France","institution_ids":["https://openalex.org/I4210143497"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086076230","display_name":"St\u00e9phanie Chanteux","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143497","display_name":"Innate Pharma (France)","ror":"https://ror.org/055wa9133","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210143497"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"St\u00e9phanie Chanteux","raw_affiliation_strings":["3INNATE PHARMA, Marseilles, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3INNATE PHARMA, Marseilles, France","institution_ids":["https://openalex.org/I4210143497"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061502185","display_name":"Laurent Gauthier","orcid":"https://orcid.org/0000-0003-3225-4825","observed_orcids":["https://orcid.org/0000-0003-3225-4825"]},"institutions":[{"id":"https://openalex.org/I4210143497","display_name":"Innate Pharma (France)","ror":"https://ror.org/055wa9133","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210143497"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Laurent Gauthier","raw_affiliation_strings":["3INNATE PHARMA, Marseilles, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3INNATE PHARMA, Marseilles, France","institution_ids":["https://openalex.org/I4210143497"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079765964","display_name":"C\u00e9cile Bonnafous","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143497","display_name":"Innate Pharma (France)","ror":"https://ror.org/055wa9133","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210143497"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"C\u00e9cile Bonnafous","raw_affiliation_strings":["3INNATE PHARMA, Marseilles, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3INNATE PHARMA, Marseilles, France","institution_ids":["https://openalex.org/I4210143497"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Benjamin Rossi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143497","display_name":"Innate Pharma (France)","ror":"https://ror.org/055wa9133","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210143497"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Benjamin Rossi","raw_affiliation_strings":["3INNATE PHARMA, Marseilles, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3INNATE PHARMA, Marseilles, France","institution_ids":["https://openalex.org/I4210143497"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070619706","display_name":"Mathieu Bl\u00e9ry","orcid":"https://orcid.org/0000-0003-4738-6038","observed_orcids":["https://orcid.org/0000-0003-4738-6038"]},"institutions":[{"id":"https://openalex.org/I4210143497","display_name":"Innate Pharma (France)","ror":"https://ror.org/055wa9133","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210143497"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Mathieu Bl\u00e9ry","raw_affiliation_strings":["3INNATE PHARMA, Marseilles, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3INNATE PHARMA, Marseilles, France","institution_ids":["https://openalex.org/I4210143497"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051292571","display_name":"Carine Paturel","orcid":"https://orcid.org/0009-0005-0780-3724","observed_orcids":["https://orcid.org/0009-0005-0780-3724"]},"institutions":[{"id":"https://openalex.org/I4210143497","display_name":"Innate Pharma (France)","ror":"https://ror.org/055wa9133","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210143497"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Carine Paturel","raw_affiliation_strings":["3INNATE PHARMA, Marseilles, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3INNATE PHARMA, Marseilles, France","institution_ids":["https://openalex.org/I4210143497"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040446667","display_name":"Armand Bensussan","orcid":"https://orcid.org/0000-0002-0409-2497","observed_orcids":["https://orcid.org/0000-0002-0409-2497"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210091437","display_name":"Sorbonne Paris Cit\u00e9","ror":"https://ror.org/001z21q04","country_code":"FR","type":"other","lineage":["https://openalex.org/I204730241","https://openalex.org/I4210091437"]},{"id":"https://openalex.org/I4210144610","display_name":"H\u00f4pital Saint-Louis","ror":"https://ror.org/049am9t04","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210144610"]},{"id":"https://openalex.org/I4387154437","display_name":"HIPI -  Immunologie humaine, physiopathologie et immunith\u00e9rapie","ror":"https://ror.org/008e1sp22","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I204730241","https://openalex.org/I4387154437"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Armand Bensussan","raw_affiliation_strings":["1INSERM U976, H\u00f4pital Saint Louis, Paris, France","2University Paris Diderot, Sorbonne Paris Cit\u00e9, UMRS 976, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1INSERM U976, H\u00f4pital Saint Louis, Paris, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210144610","https://openalex.org/I4387154437"]},{"raw_affiliation_string":"2University Paris Diderot, Sorbonne Paris Cit\u00e9, UMRS 976, Paris, France","institution_ids":["https://openalex.org/I4210091437","https://openalex.org/I4387154437"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068469347","display_name":"Martine Bagot","orcid":"https://orcid.org/0000-0002-1631-5192","observed_orcids":["https://orcid.org/0000-0002-1631-5192","https://orcid.org/0000-0002-0400-1954"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210091437","display_name":"Sorbonne Paris Cit\u00e9","ror":"https://ror.org/001z21q04","country_code":"FR","type":"other","lineage":["https://openalex.org/I204730241","https://openalex.org/I4210091437"]},{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]},{"id":"https://openalex.org/I4210144610","display_name":"H\u00f4pital Saint-Louis","ror":"https://ror.org/049am9t04","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210144610"]},{"id":"https://openalex.org/I4387154437","display_name":"HIPI -  Immunologie humaine, physiopathologie et immunith\u00e9rapie","ror":"https://ror.org/008e1sp22","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I204730241","https://openalex.org/I4387154437"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Martine Bagot","raw_affiliation_strings":["1INSERM U976, H\u00f4pital Saint Louis, Paris, France","2University Paris Diderot, Sorbonne Paris Cit\u00e9, UMRS 976, Paris, France","4AP-HP, H\u00f4pital Saint Louis, Department of Dermatology, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1INSERM U976, H\u00f4pital Saint Louis, Paris, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210144610","https://openalex.org/I4387154437"]},{"raw_affiliation_string":"2University Paris Diderot, Sorbonne Paris Cit\u00e9, UMRS 976, Paris, France","institution_ids":["https://openalex.org/I4210091437","https://openalex.org/I4387154437"]},{"raw_affiliation_string":"4AP-HP, H\u00f4pital Saint Louis, Department of Dermatology, Paris, France","institution_ids":["https://openalex.org/I4210097159","https://openalex.org/I4210144610"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5043894926","display_name":"H\u00e9l\u00e8ne Sicard","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143497","display_name":"Innate Pharma (France)","ror":"https://ror.org/055wa9133","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210143497"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"H\u00e9l\u00e8ne Sicard","raw_affiliation_strings":["3INNATE PHARMA, Marseilles, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3INNATE PHARMA, Marseilles, France","institution_ids":["https://openalex.org/I4210143497"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":6.8447,"has_fulltext":false,"cited_by_count":89,"citation_normalized_percentile":{"value":0.97250752,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"74","issue":"21","first_page":"6060","last_page":"6070"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11811","display_name":"Cutaneous lymphoproliferative disorders research","score":0.9868000149726868,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11811","display_name":"Cutaneous lymphoproliferative disorders research","score":0.9868000149726868,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.002899999963119626,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/kir3dl2","display_name":"KIR3DL2","score":0.9739999771118164},{"id":"https://openalex.org/keywords/cutaneous-t-cell-lymphoma","display_name":"cutaneous T-cell lymphoma","score":0.9850000143051147},{"id":"https://openalex.org/keywords/sezary-syndrome","display_name":"S\u00e9zary syndrome","score":0.9449999928474426},{"id":"https://openalex.org/keywords/humanized-antibody","display_name":"humanized monoclonal antibody","score":0.9890000224113464},{"id":"https://openalex.org/keywords/antibody-dependent-cellular-cytotoxicity","display_name":"antibody-dependent cellular cytotoxicity","score":0.890999972820282},{"id":"https://openalex.org/keywords/phagocytosis","display_name":"phagocytosis","score":0.9729999899864197},{"id":"https://openalex.org/keywords/natural-killer-cells","display_name":"natural killer cells","score":0.8190000057220459},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.5},{"id":"https://openalex.org/keywords/mouse-tumor-model","display_name":"mouse tumor model","score":0.5479999780654907}],"concepts":[{"id":"https://openalex.org/C2776780870","wikidata":"https://www.wikidata.org/wiki/Q5196687","display_name":"Cutaneous T-cell lymphoma","level":4,"score":0.7255042791366577},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6302860975265503},{"id":"https://openalex.org/C137061746","wikidata":"https://www.wikidata.org/wiki/Q736033","display_name":"Peripheral blood mononuclear cell","level":3,"score":0.5750001072883606},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.5667155385017395},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5564574599266052},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.5518204569816589},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5403521060943604},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.510405957698822},{"id":"https://openalex.org/C2777756187","wikidata":"https://www.wikidata.org/wiki/Q1891209","display_name":"Mycosis fungoides","level":3,"score":0.48610496520996094},{"id":"https://openalex.org/C2776156784","wikidata":"https://www.wikidata.org/wiki/Q3491954","display_name":"Humanized mouse","level":3,"score":0.47407665848731995},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4642760157585144},{"id":"https://openalex.org/C26291073","wikidata":"https://www.wikidata.org/wiki/Q310484","display_name":"Ex vivo","level":3,"score":0.46391668915748596},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.46101701259613037},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.3561343252658844},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.20027127861976624},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.15617966651916504},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.13224750757217407},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000920","descriptor_name":"Antibody-Dependent Cell Cytotoxicity","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009367","descriptor_name":"Neoplasm Staging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016410","descriptor_name":"Lymphoma, T-Cell, Cutaneous","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016410","descriptor_name":"Lymphoma, T-Cell, Cutaneous","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D016410","descriptor_name":"Lymphoma, T-Cell, Cutaneous","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054347","descriptor_name":"Receptors, KIR3DL2","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D054347","descriptor_name":"Receptors, KIR3DL2","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1158/0008-5472.can-14-1456","doi":"https://doi.org/10.1158/0008-5472.can-14-1456","is_oa":false,"landing_page_url":"https://doi.org/10.1158/0008-5472.can-14-1456","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},{"id":"pmid:25361998","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25361998","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":57,"referenced_works":["https://openalex.org/W29986303","https://openalex.org/W1576025436","https://openalex.org/W1593874097","https://openalex.org/W1965962344","https://openalex.org/W1966015345","https://openalex.org/W1969618730","https://openalex.org/W1970432040","https://openalex.org/W1980144339","https://openalex.org/W1982215720","https://openalex.org/W1992712621","https://openalex.org/W2001829722","https://openalex.org/W2007399919","https://openalex.org/W2015948025","https://openalex.org/W2016373265","https://openalex.org/W2017098129","https://openalex.org/W2022088271","https://openalex.org/W2024397914","https://openalex.org/W2027288274","https://openalex.org/W2027517469","https://openalex.org/W2028658315","https://openalex.org/W2042551060","https://openalex.org/W2044360617","https://openalex.org/W2052022127","https://openalex.org/W2057745345","https://openalex.org/W2057910076","https://openalex.org/W2081737680","https://openalex.org/W2091378658","https://openalex.org/W2091472630","https://openalex.org/W2095134978","https://openalex.org/W2096160655","https://openalex.org/W2100103468","https://openalex.org/W2106217554","https://openalex.org/W2109687784","https://openalex.org/W2110890034","https://openalex.org/W2122080125","https://openalex.org/W2130930654","https://openalex.org/W2134003255","https://openalex.org/W2135802989","https://openalex.org/W2137448956","https://openalex.org/W2139891818","https://openalex.org/W2146682305","https://openalex.org/W2153313108","https://openalex.org/W2154749163","https://openalex.org/W2155959492","https://openalex.org/W2156784283","https://openalex.org/W2162093324","https://openalex.org/W2162841438","https://openalex.org/W2167282403","https://openalex.org/W2169489656","https://openalex.org/W2171010115","https://openalex.org/W2173547083","https://openalex.org/W2312229826","https://openalex.org/W2615479722","https://openalex.org/W2768338596","https://openalex.org/W2979542832","https://openalex.org/W2980269556","https://openalex.org/W6768910523"],"related_works":["https://openalex.org/W2593445710","https://openalex.org/W1525133299","https://openalex.org/W2955680602","https://openalex.org/W2496203774","https://openalex.org/W1567562441","https://openalex.org/W2623252201","https://openalex.org/W2972080728","https://openalex.org/W2949841033","https://openalex.org/W2953746728","https://openalex.org/W2053118326"],"abstract_inverted_index":{"Advanced":[0],"cutaneous":[1],"T-cell":[2],"lymphoma":[3],"(CTCL)":[4],"remains":[5],"an":[6],"unmet":[7],"medical":[8],"need,":[9],"which":[10,34],"lacks":[11],"effective":[12],"targeted":[13],"therapies.":[14],"In":[15,115],"this":[16],"study,":[17],"we":[18],"report":[19],"the":[20,30,144],"development":[21,146],"of":[22,49,62,132,141,147],"IPH4102,":[23],"a":[24,59],"humanized":[25],"monoclonal":[26],"antibody":[27],"that":[28],"targets":[29],"immune":[31,44],"receptor":[32],"KIR3DL2,":[33],"is":[35],"widely":[36],"expressed":[37],"on":[38],"CTCL":[39,56],"cells":[40,57],"but":[41],"few":[42],"normal":[43],"cells.":[45,114],"Potent":[46],"antitumor":[47,66],"properties":[48],"IPH4102":[50,65,76,118,148],"were":[51],"documented":[52],"in":[53,83,95],"allogeneic":[54],"human":[55],"and":[58,74,79,105,120],"mouse":[60],"model":[61],"KIR3DL2(+)":[63,87],"disease.":[64],"activity":[67],"was":[68,92],"mediated":[69],"by":[70],"antibody-dependent":[71],"cell":[72],"cytotoxicity":[73],"phagocytosis.":[75],"improved":[77],"survival":[78],"reduced":[80],"tumor":[81],"growth":[82],"mice":[84],"inoculated":[85],"with":[86,152],"tumors.":[88],"Ex":[89],"vivo":[90],"efficacy":[91],"further":[93],"evaluated":[94],"primary":[96,123],"S\u00e9zary":[97,109,124],"patient":[98,110],"cells,":[99,125],"sorted":[100],"natural":[101],"killer-based":[102],"autologous":[103],"assays,":[104],"direct":[106],"spiking":[107],"into":[108],"peripheral":[111],"blood":[112],"mononuclear":[113],"these":[116],"settings,":[117],"selectively":[119],"efficiently":[121],"killed":[122],"including":[126],"at":[127],"unfavorable":[128],"effector-to-target":[129],"ratios":[130],"characteristic":[131],"unsorted":[133],"PBMC.":[134],"Together,":[135],"our":[136],"results":[137],"offer":[138],"preclinical":[139],"proof":[140],"concept":[142],"for":[143],"clinical":[145],"to":[149],"treat":[150],"patients":[151],"advanced":[153],"CTCL.":[154]},"counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":11},{"year":2020,"cited_by_count":10},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":10},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":4},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2016-06-24T00:00:00"}